Influence of trimetazidine on echocardiography parameters and free radical stress index in coronary artery disease and end-stage renal failure patients treated by hemodialysis - Preliminary communication;Wpływ trimetazydyny na wybrane wskaźniki echokardiograficzne i wskaźnik stresu oksydacyjnego u chorych na chorobe(Combining ogonek sign) wieńcowa(Combining ogonek sign) i z nieodwracalna(Combining ogonek sign) niewydolnościa(Combining ogonek sign) nerek leczonych hemodializami - Doniesienie wste(Combining ogonek sign)pne

Polskie Archiwum Medycyny Wewnetrznej

Volumn 102, Issue 1, 1999, Pages 589-594

  Wierzbicki, Przemysław ^a   Cwetsch, Andrzej ^b   Fijałkowski, Paweł ^c   Wańkowicz, Zofia ^a  

^a Dializ Instytutu Medycyny W   (Poland)

^b Klinika Chorob Wewnetrznych i C   (Poland)

^c Zaklad Fizjologii Instytutu N

Author keywords

Echocardiography; End stage renal disease; Hemodialysis; Ischaemic heart disease; Malonylodialdehyde; Trimetazidine

Indexed keywords

FREE RADICAL; TRIMETAZIDINE; VASODILATOR AGENT; MALONALDEHYDE;

ARTICLE; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEMODIALYSIS; KIDNEY FAILURE; STRESS;

CORONARY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FREE RADICALS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 6244234789     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Grynberg A. i wsp.: Some biochemical aspects of the protective effect of TMZ on rat cardiomyocytes during hypoxia and reoxygenation. J. Moll. Cell. Cardiol., 1994, 26, 949.
2. Singh B. i wsp.: Mechanism of action of a novel metabolically active antianginal agent (trimetazidine) delineated by PET. J. Am. Coll. Cardiol., 1996, 27, suppl. A, 132A.
3. Grekas D i wsp.: Lipid peroxidation after renal ischaemia and reperfusion in rats effect of trimetazidine. Renal Faillure, 1996, 18, 545.
4. 31P = NMR spectroscopy in the isolated rat heart. Arch. Int. Pharmacodyn. Ther.: 1987, 286, 91.
5. Fabiani J. N. i wsp.: Cardioprotective effect of trimetazidine during coronary artery graft surgery. J. Cardiovasc. Surg., 1992, 33, 486.
6. Detry J.M. i wsp.: Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring. Am. J. Cardiol., 1995, vol 76, 23.
7. Michaelides A.P. i wsp.: Lipid peroxidation after acute renal ischaemia and reperfusion in rats: the effect of trimetazidine. Clin. Drug. Invest., 1997, Jan, 13,234.
8. Szwed H. i wsp.: Skuteczność i tolerancja trimetazydyny jako leku wieńcowego u chorych z wysiłkowa(Combining ogonek sign) dusznica(Combining ogonek sign) bolesna(Combining ogonek sign) w skojarzeniu z jednym lekiem przeciwdławicowym. ESS, 1997, 4, 237.
9. Konstantynowicz H., Tracz M., Janion C. i wsp.: Echokardiografia w ocenie struktur serca u chorych z przewlekła(Combining ogonek sign) niewydolnościa, nerek. Nefrol. Dial. Pol., 1998, 2, 43.
10. Foley R.N., Parfrey S.P., Harnett J.D. i wsp.: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int., 1995, 47, 186.
11. Aquatella M.A., Peres-Rojas M., Burger B. i wsp.: Left ventricular function in terminal uraemia. Nephron., 1978, 22, 160.
12. Fesslowa V., Visconti di Massino U., Strucchi C. i wsp.: Multifactorial anylysis of the cardiocirculatory compromise in children with chronic renal insufficiency in hemodialysis. An echocardiographic study. G. Ital. Cardiol., 1986, 16-17, 551.
13. Metha B.R., Ireland M.A., Shiu M.F.: Echocardiographic evaluation of cardiac size and function in dialysis patients. Clin., Nephrol., 1984, 20, 62.
14. Lu C., Da(Combining ogonek sign)browski P., Fragasso G., Chierchia S.L.: Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease. Am. J. Cardiol., 1998, 82, 898.